Stockreport

This Under-the-Radar Stock Is Up by 96% This Year: Time to Buy? [Yahoo! Finance]

Inovio Pharmaceuticals, Inc.  (INO) 
NASDAQ:AMEX Investor Relations: ir.inovio.com/investors/default.aspx
PDF Its bet to become a leader in this field fell flat, the company largely fell into irrelevance, and its value decreased substantially. However, Inovio isn't dead in the [Read more]